Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Trifluoperazine 5mg/5ml oral solution sugar free
0402010X0AAAKAK
|
Trifluoperazine | Trifluoperazine | Central Nervous System | 4,705 |
|
Trifluoperazine 1mg tablets
0402010X0AAAHAH
|
Trifluoperazine | Trifluoperazine | Central Nervous System | 2,085 |
|
Trifluoperazine 5mg tablets
0402010X0AAAIAI
|
Trifluoperazine | Trifluoperazine | Central Nervous System | 2,043 |
|
Trifluoperazine 1mg/5ml oral solution sugar free
0402010X0AAAFAF
|
Trifluoperazine | Trifluoperazine | Central Nervous System | 57 |
|
Trifluoperazine 10mg modified-release capsules
0402010X0AAABAB
|
Trifluoperazine | Trifluoperazine | Central Nervous System | No data available |
|
Trifluoperazine 15mg modified-release capsules
0402010X0AAACAC
|
Trifluoperazine | Trifluoperazine | Central Nervous System | No data available |
|
Trifluoperazine 1mg/5ml oral suspension
0402010X0AAALAL
|
Trifluoperazine | Trifluoperazine | Central Nervous System | No data available |
|
Trifluoperazine 2mg modified-release capsules
0402010X0AAAAAA
|
Trifluoperazine | Trifluoperazine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.